December 3rd & 4th, 2024
IN-PERSON | LILLE, FR
December 11th& 12th 2024
ONLINE MEETINGS
Dec 3rd & 4th, 2024
IN-PERSON | LILLE, FR
Dec 11th& 12th, 2024
ONLINE MEETINGS
Home » Innovative Solution Providers’ workshop
Innovative Solution Providers’ workshop:
How do we keep you in the race of Covid-19?
Monday, December 7th, 2020
11.15 am – 12.30 pm CET
Infectious diseases are caused by pathogenic micro-organisms, such as bacteria, viruses, parasites or fungi; diseases can be transmitted, directly or indirectly, from one person to another.
Three infectious diseases have been ranked among the top ten causes of death worldwide in 2016 by the World Health Organization. These are lower respiratory tract infections (3.0 million deaths), diarrheal diseases (1.4 million deaths) and tuberculosis (1.3 million deaths).
Despite significant progress in research and treatments for infectious diseases, the control and eradication of these diseases still face major challenges. We are currently facing a new emerging infectious disease with the global COVID-19 outbreak caused by the SARS-CoV-2 virus, a type of coronavirus part of a group of RNA viruses (that cause diseases in mammals and birds). Both public research and pharmaceutical industry have been mobilized to find ways to speed up the launch of prophylactic or therapeutic solutions. We have to be SMART to win the race against COVID-19. Different options can be considered, such as substantial investments, drug repositioning, massive consolidation of pharmaceutical companies.
Faced with this fast-paced demand from the pharmaceutical industry, the CROs are coming together to respond quickly and ingeniously to this unprecedented health crisis.
Come and listen to Innovative Providers’ solutions. We will unveil our continuum of specialties to unlock the scientific padlocks linked to Covid-19.
The Innovative Solution Providers gathers French based companies, Oncodesign, Cynbiose, ERBC & PharmaLex. They set-up this specialties companies network to provide the biotech and pharma industry with a full-service offering ranging from hit findings, preclinical research to regulatory developments. These partners have seen an opportunity to provide greater added value services to clients worldwide.
Key learning objectives
With more than 1,000 international actors from 35+ countries, such as big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment rounds in Life Sciences.
Learn more
Organised by:
WITH THE SUPPORT OF:
INSTITUTIONAL PARTNERS:
"*" indicates required fields
Lille Grand Palais
1, Boulevard des Cités Unies
59777 Lille, FRANCE
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
WARNING: Some fraudulent companies are supposedly providing the attendees list of BioFIT. And some are passing themselves off as being BioFIT organisation members and asking you to pay. Please note that the BioFIT team will never sell you the BioFIT attendees list and never ask for your bank account details to make you pay for hotel bookings, exhibition fees or others, and certainly not over the phone.Please be extremely vigilant.